Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single-cell assay for transposase-accessible chromatin sequencing of human clear cell renal cell carcinoma

ABSTRACT: Single-cell assay for transposase-accessible chromatin sequencing of human clear cell renal cell carcinoma

PROVIDER: PRJNA1130842 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29676437_1.fastq.gz	Fastqsanger.gz
	SRR29676437_2.fastq.gz	Fastqsanger.gz
	SRR29676438_1.fastq.gz	Fastqsanger.gz
	SRR29676438_2.fastq.gz	Fastqsanger.gz
	SRR29676439_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Single-cell assay for transposase-accessible chromatin sequencing of human clear cell renal cell carcinoma

Project description:In recent years, with the development of single-cell sequencing technology, it has become possible to perform single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq), especially the high-throughput single-cell analysis. Here, we provide a high-quality chromatin accessibility data for ccRCC at single-cell level. Performing high-throughput scATAC-seq on 3 human ccRCC samples (RCC30, RCC61 and RCC76), we obtained a total of 18,703 high quality nuclei and 104,818 unique peaks, including coding, non-coding regions, promoters and enhancers.we demonstrate a complete analysis process for scATAC-seq data, and makes the application more feasible and convenient.

2025-01-24 | GSE271273 | GEO

Assay for Transposase-Accessible Chromatin in E4BP4 overexpressed RAW264.7 cells

Project description:Assay for Transposase-Accessible Chromatin in E4BP4 overexpressed RAW264.7 cells

| PRJNA978597 | ENA

Assay for Transposase Accessible Chromatin (ATAC)-sequencing of the AML cell line U937

Project description:Assay for Transposase Accessible Chromatin (ATAC)-sequencing of the AML cell line U937

| PRJNA788787 | ENA

Single-cell assay for transposase-accessible chromatin sequencing of human clear cell renal cell carcinoma.

Project description:Regulating the occurrence and progression of tumor cells at the epigenetic level is a new insight of clear cell renal cell carcinoma (ccRCC). Chromatin accessibility is an important pathway of epigenetic regulation, which may explain the mystery of tumor occurrence. Assay for transposase-accessible chromatin sequencing (ATAC-seq) provides insight into the epigenetic regulatory features of ccRCC, especially at the single-cell level. In this study, we performed scATAC-seq of 3 ccRCC samples and captured a total of 18,703 high-quality cell nuclei and 104,818 unique peaks. Our protocol for nuclear extraction was reliable and stable, which can be used to deal with fresh and frozen single-cell suspensions. We presented basic methods for scATAC-seq data analysis, such as cell clustering, gene activity scoring, cell subtype specific peaks, transcription factors, motif and motif footprinting analysis. Taken together, our data indicated the valuable epigenetic features of ccRCC, which will provide more references for the study of ccRCC.

| S-EPMC11861977 | biostudies-literature

Assay for Transposase-Accessible Chromatin using sequencing of spleen memory CD4+ T cells

Project description:Assay for Transposase-Accessible Chromatin using sequencing of spleen memory CD4+ T cells

| PRJNA579595 | ENA

ATAC-seq(Assay of Transposase Accessible Chromatin with High-throughput sequencing) after ER stress

Project description:ATAC-seq(Assay of Transposase Accessible Chromatin with High-throughput sequencing) after ER stress

| PRJNA858030 | ENA

Assay for Transposase-Accessible Chromatin sequencing (ATAC-seq) of primary melanocytes from five human donors

Project description:Assay for Transposase-Accessible Chromatin sequencing (ATAC-seq) of primary melanocytes from five human donors

| PRJEB88675 | ENA

Assay for transposase-accessible chromatin with sequencing (ATAC-seq) after various treatments in T47D cells

Project description:Assay for transposase-accessible chromatin with sequencing (ATAC-seq) after various treatments in T47D cells

| PRJNA1055469 | ENA

Optimized protocol for assay for transposase-accessible chromatin by sequencing (ATAC-seq) from Drosophila melanogaster brain tissue

Project description:Transposase-accessible chromatin by sequencing (ATAC-seq) has emerged as an advantageous technique to assess chromatin accessibility owing to the robustness of "tagmentation" process and a relatively faster library preparation. A comprehensive ATAC-seq protocol from Drosophila brain tissue is currently unavailable. Here, we have provided a detailed protocol of ATAC-seq assay from Drosophila brain tissue. Starting from dissection and transposition to amplification of libraries has been elaborated. Furthermore, a robust ATAC-seq analysis pipeline has been presented. The protocol can be easily adapted for other soft tissues.

2023-10-24 | GSE246106 | GEO

Iterative assay for transposase-accessible chromatin by sequencing to home in on functionally relevant neuronal subtypes

Project description:The Drosophila brain contains tens of thousands of distinct cell types. Numerous different transgenic lines reproducibly target specific neuron subsets, yet most still express in several distinct cell types. Furthermore, most lines were developed without a priori knowledge of where the transgenes would be expressed. To aid in the development of cell type-specific tools for neuronal identification and manipulation, we used an iterative assay for transposase-accessible chromatin by sequencing (ATAC-seq) approach. Open chromatin regions (OCRs) that were enriched in neurons compared to whole bodies drove transgene expression preferentially in subsets of neurons. A second round of ATAC-seq from these specific neuron subsets revealed additional enriched OCRs that further restricted transgene expression within the chosen neuron subset. This approach allows for continued refinement of transgene expression and can be used to identify neurons relevant for sleep behavior. Furthermore, this approach is widely applicable to other cell types and to other organisms.

2024-02-28 | GSE226514 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data